2nd Aug 2018 13:23
LONDON (Alliance News) - NetScientific PLC said Thursday its portfolio company ProAxsis Ltd has successfully registered a CE Mark for its third respiratory immunoassay.
The CE Mark has been followed by a GBP5,000 sale to a US-based biotechnology company.
"The immunoassay will be marketed to clinical researchers investigating chronic respiratory conditions in both the commercial sector and academia," the company said.
NetScientific shares were untraded at 35.00 pence each Thursday.
Related Shares:
Netscientific